Erlotinib hydrochloride

CAS No.:183319-69-9

TBW04381
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride;ERLOTINIB;ERLOTINIB HCL SALT;TARCEVA;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-;quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva;N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva Hydrochloride See E625000;Erlotinib HCl;Erlotinib hydrochloride;Erlotinib HCl (OSI-744);[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine;Erlotinib Hydrochlorid;Erlotinib Hydrochloride (Tarceva);Erlotinib, Hydrochloride Salt (Tarceva®);N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-quinazolin-4-amine hydrochloride;Tarceva (Erlotinib Hydrochloride);(±)-Cloprostenol; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;CP-358774;Erlotinib (Hydrochloride);Erlotinib,OS-774;Erlotinib-d6 HCl;Erlotonid HCl;NSC 718781;OSI 774;OSI-774;774 hydrochloride;CP-358;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride;OSI-744 hydrochloride;N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride;RG-1415;CP 358774;RO-0508231;CP-358774-01;DA87705X9K;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1);6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hcl;(CP358774;N-(3-ethynylphenyl)-6,7;Erlotinib Hydrochloride;N-(3-Ethynylphenyl)-6,7-bis(1-methoxyethoxy)-4-quinazolinamine hydrochloride;CHEBI:53509;NSC-718781;Erlotinib 13C6 HCl;Erlotinib hydrochloride [USAN:INN];183319-69-9 (HCl);CHEMBL1079742;AC-400;EN300-123054;C22H24ClN3O4;SMR002529980;s1023;n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride;183319-69-9;ERLOTINIB HYDROCHLORIDE [USP-RS];DTXCID7093903;N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride;BP-30224;CP-358,774-01;OSI-744;4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride;KS-1202;MFCD07781272;GTTBEUCJPZQMDZ-UHFFFAOYSA-N;F0001-2385;DTXSID10171412;erlotinib, hydrochloride salt;NSC 718781) HCl;FT-0651479;Erlotinib hydrochlroide;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine monohydrochloride;183319-69-9 pound not183321-74-6;ERLOTINIB HYDROCHLORIDE [ORANGE BOOK];Erlotinib Hydrochloride,CP-358774, OSI-774, NSC 718781;6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;N-(3-ETHENYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, monohydrochloride;PB30965;NSC718781;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride;EX-A064;Tarceva (OSI);[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydro...
inquiry
C22H24CLN3O4
429.90

Product introduction

Category: Product
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: Cl[H].O(C([H])([H])C([H])([H])OC([H])([H])[H])C1C([H])=C2C(=NC([H])=NC2=C([H])C=1OC([H])([H])C([H])([H])OC([H])([H])[H])N([H])C1=C([H])C([H])=C([H])C(C#C[H])=C1[H]